High diagnostic efficacy of 5-aminolevulinic acid-induced fluorescent urine cytology for urothelial carcinoma.
5-Aminolevulinic acid
Cytology
Sensitivity
Specificity
Urothelial carcinoma
Journal
International journal of clinical oncology
ISSN: 1437-7772
Titre abrégé: Int J Clin Oncol
Pays: Japan
ID NLM: 9616295
Informations de publication
Date de publication:
Sep 2019
Sep 2019
Historique:
received:
29
11
2018
accepted:
04
04
2019
pubmed:
13
4
2019
medline:
27
11
2019
entrez:
13
4
2019
Statut:
ppublish
Résumé
In general, urine cytology is often problematic because of its low sensitivity, especially for low-grade urothelial carcinoma (UC) in clinical practice. To improve the sensitivity, we focused on 5-aminolevulinic acid (5-ALA), because recent studies suggested that 5-ALA-induced urine cytology can be used for photodynamic diagnosis. In this study, we evaluated the diagnostic efficacy of 5-ALA-induced fluorescent urine cytology for UC. We included in this study 318 patients comprising 158 non-cancer patients, 84 bladder tumor patients, and 76 upper urinary tract urothelial carcinoma (UUT-UC) patients treated in our institution from March 2013 to September 2018. Using the same voided urine sample, we compared sensitivity and specificity between conventional urine cytology and 5-ALA-induced fluorescent urine cytology. Overall, the sensitivity of 5-ALA-induced fluorescent urine cytology was significantly higher than that of conventional urine cytology (86.9% vs. 69.4%; p = 0.0002), and the specificity was equivalently high (96.2% vs. 95.6%; p = 1.0). In subgroup analysis, the high sensitivity of 5-ALA-induced fluorescent urine cytology was also detected regardless of age, sex, and tumor type. However, in terms of stage and grade, differences were only detected in patients with less than pTa stage (89.2% vs. 52.1%; p = 0.0001) and low-grade tumor (91.5% vs. 51.1%; p < 0.0001). 5-ALA-induced fluorescent urine cytology was significantly more effective for UC diagnosis when compared with the conventional cytology, especially in patients with low-stage and low-grade tumors. These findings indicate that 5-ALA-induced fluorescent urine cytology may potentially be a very useful tool for clinical use.
Sections du résumé
BACKGROUND
BACKGROUND
In general, urine cytology is often problematic because of its low sensitivity, especially for low-grade urothelial carcinoma (UC) in clinical practice. To improve the sensitivity, we focused on 5-aminolevulinic acid (5-ALA), because recent studies suggested that 5-ALA-induced urine cytology can be used for photodynamic diagnosis. In this study, we evaluated the diagnostic efficacy of 5-ALA-induced fluorescent urine cytology for UC.
METHODS
METHODS
We included in this study 318 patients comprising 158 non-cancer patients, 84 bladder tumor patients, and 76 upper urinary tract urothelial carcinoma (UUT-UC) patients treated in our institution from March 2013 to September 2018. Using the same voided urine sample, we compared sensitivity and specificity between conventional urine cytology and 5-ALA-induced fluorescent urine cytology.
RESULTS
RESULTS
Overall, the sensitivity of 5-ALA-induced fluorescent urine cytology was significantly higher than that of conventional urine cytology (86.9% vs. 69.4%; p = 0.0002), and the specificity was equivalently high (96.2% vs. 95.6%; p = 1.0). In subgroup analysis, the high sensitivity of 5-ALA-induced fluorescent urine cytology was also detected regardless of age, sex, and tumor type. However, in terms of stage and grade, differences were only detected in patients with less than pTa stage (89.2% vs. 52.1%; p = 0.0001) and low-grade tumor (91.5% vs. 51.1%; p < 0.0001).
CONCLUSIONS
CONCLUSIONS
5-ALA-induced fluorescent urine cytology was significantly more effective for UC diagnosis when compared with the conventional cytology, especially in patients with low-stage and low-grade tumors. These findings indicate that 5-ALA-induced fluorescent urine cytology may potentially be a very useful tool for clinical use.
Identifiants
pubmed: 30976938
doi: 10.1007/s10147-019-01447-5
pii: 10.1007/s10147-019-01447-5
doi:
Substances chimiques
Aminolevulinic Acid
88755TAZ87
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1075-1080Références
BJU Int. 2001 Nov;88(7):692-701
pubmed: 11890239
J Urol. 2003 Jun;169(6):1975-82
pubmed: 12771702
JAMA. 2006 Jan 18;295(3):299-305
pubmed: 16418465
Curr Opin Urol. 2006 Sep;16(5):372-6
pubmed: 16905985
World J Urol. 2008 Feb;26(1):51-8
pubmed: 18058108
Eur Urol. 2008 Jun;53(6):1138-48
pubmed: 18096307
Photochem Photobiol Sci. 2008 Mar;7(3):283-9
pubmed: 18389144
Cancer. 2012 Feb 15;118(4):1062-74
pubmed: 21773973
Radiology. 2012 Jul;264(1):110-8
pubmed: 22495683
Photodiagnosis Photodyn Ther. 2013 Sep;10(3):288-95
pubmed: 23993855
Photodiagnosis Photodyn Ther. 2015 Jun;12(2):282-8
pubmed: 25595357
Photodiagnosis Photodyn Ther. 2015 Jun;12(2):193-200
pubmed: 25843912
Eur Urol. 2015 Nov;68(5):868-79
pubmed: 26188393
Photodiagnosis Photodyn Ther. 2016 Mar;13:225-232
pubmed: 26226642
Urology. 2016 Oct;96:35-43
pubmed: 27151340
J Cancer Res Clin Oncol. 2017 Nov;143(11):2309-2316
pubmed: 28726046
BJU Int. 2018 Feb;121(2):184-193
pubmed: 29032580
Int J Clin Oncol. 2018 Dec;23(6):1140-1147
pubmed: 29971622
Br J Cancer. 1987 Nov;56(5):589-95
pubmed: 3480752
Urology. 1994 Dec;44(6):836-41
pubmed: 7985312
Cancer. 1994 Sep 1;74(5):1621-6
pubmed: 8062194
Photochem Photobiol. 1995 Nov;62(5):887-95
pubmed: 8570728